CBIO vs INBX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CBIO

47.9
AI Score
VS
CBIO Wins

INBX

47.3
AI Score

Investment Advisor Scores

CBIO

48score
Recommendation
HOLD

INBX

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO INBX Winner
Net Income -48.12M -70.09M CBIO
Operating Income -51.09M -63.08M CBIO
ROE -29.5% 132.3% INBX
ROA -26.3% -45.4% CBIO
Total Assets 182.76M 154.22M CBIO
Cash 171.59M 133.34M CBIO
Current Ratio 9.66 5.07 CBIO

Relative Price Performance (Last 90 Days)

CBIO 1M: +14.2% · 3M: -16.2% INBX 1M: +2.9% · 3M: -0.7%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $14.37

INBX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $87.75

Fundamentals Snapshot

Metric CBIO INBX
Market Cap — —
Forward P/E -5.5 -10.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin 1.0% —
Operating Margin -14.3% 0.0%
EPS -7.20 -8.89
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.